Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Roche,Atezolizumab,"Urothelial carcinoma, locally advanced or metastatic, 2nd line",Atezolizumab,Hospital,Oncology Agents and Immunosuppressants
